Open Access Research article

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

S Yousuf Zafar12*, Jennifer L Malin34, Steven C Grambow25, David H Abbott2, Deborah Schrag6, Jane T Kolimaga27, Leah L Zullig28, Jane C Weeks9, Mona N Fouad10, John Z Ayanian11, Robert Wallace12, Katherine L Kahn13, Patricia A Ganz14, Paul Catalano15, Dee W West16, Dawn Provenzale27 and the Cancer Care and Outcomes Research and Surveillance (CanCORS) Consortium

Author Affiliations

1 Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA

2 Center for Health Services Research in Primary Care, DDurham VA Medical Center, Durham, NC, USA

3 Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA

4 Division of Hematology and Medical Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA

5 Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA

6 Dana-Farber Cancer Institute, Boston, MA, USA

7 Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC, USA

8 University of North Carolina at Chapel Hill, Department of Health Policy and Management, Chapel Hill, NC, USA

9 Department of Health Policy and Management, Dana Farber Cancer Institute, Boston, MA, USA

10 Division of Preventative Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

11 Department of Health Care Policy, Harvard Medical School, and Division of General Medicine, Brigham and Women's Hospital Boston, MA, USA

12 Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA

13 RAND Corporation, Santa Monica, CA; and Divisions of General Internal Medicine & Health Services Research, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA

14 School of Public Health, University of California, Los Angeles, CA, USA

15 Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA

16 Northern California Cancer Center, Fremont, CA; and Stanford School of Medicine, Stanford, CA, USA

For all author emails, please log on.

BMC Cancer 2011, 11:354  doi:10.1186/1471-2407-11-354

Published: 16 August 2011

Additional files

Additional file 1:

Patient preference and belief variables that were not significantly related to receipt of chemotherapy. Table.

Format: DOC Size: 34KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data